Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

A1C, LDL, HDL… the number of medical abbreviations you might see on your patient portal is enough to make you think your doctor speaks an entirely different language. Two such acronyms you may be less ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...

Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...

In patients with metabolic abnormal fatty liver disease (MASLD), if the blood test index is low but the cirrhosis is high, the actual liver fibrosis is more severe and the risk of liver complications ...

Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ultrasound (CEUS) to help ...

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic ...

New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.